missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TOKU-E™ Ampicillin ReadyMade™ Solution
Beschreibung
- CAS Number: 69-53-4
- Molecular Formula: C16H19N3O4S (ampicillin anhydrous)
- Molecular Weight: 349.40 g/mol
- Storage Conditions: -20°C
- Form: Liquid
- Source: Semi-synthetic
- Spectrum: Ampicillin is broad-spectrum, effective against both Gram-positive and Gram-negative bacteria including Gram-negative non-extended spectrum β-lactamase (ESBL) bacteria including Staphylococcus and Streptococcus species and medically important enteric pathogens such as Shigella and Salmonella. Interestingly, Ampicillin has been found to be effective against certain β-lactam sensitive vancomycin-resistant Enterococcus (VRE); a glycopeptide antibiotic resistant 'superbug'. Resistance to Ampicillin is routinely used as a selectable marker to confirm successful cell transformation
- Mechanism of Action: Like all β-lactams, Ampicillin interferes with penicillin binding protein (PBP) activity, otherwise involved in the final phase of peptidoglycan synthesis. PBPs are enzymes which catalyze a pentaglycine crosslink between alanine and lysine residues. Without a pentaglycine crosslink, the integrity of the cell wall is severely compromised ultimately leading to cell lysis
Spezifikation
Spezifikation
| CAS | 69-53-4 |
| Zertifizierung/Konformität | Purity >98.0% |
| Chemischer Name oder Material | Ampicillin |
| Farbe | Opaque white to opaque yellow |
| Inhalt und Lagerung | -20°C |
| Beschreibung | Ampicillin Readymade™ Solution 100 mg/mL in DMSO, Sterile Filtered |
| Konzentration | 100 to 105 mg/mL |
| Form | Liquid |
| Produkttyp | Antibiotic |
| Sterilität | Sterile |
| Mehr anzeigen |
Titolo del prodotto
Facendo clic su Invia, l'utente riconosce che potrebbe essere contattato da Fisher Scientific in merito al feedback fornito in questo modulo. Non condivideremo le vostre informazioni per altri scopi. Tutte le informazioni di contatto fornite saranno conservate in conformità con la nostra Politica sulla privacy. Informativa sulla privacy.
Individuate un'opportunità di miglioramento?